Day: January 30, 2024

85 patients enrolled TORONTO, Jan. 30, 2024 (GLOBE NEWSWIRE) — Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today provided an update on the Company’s Tigris trial, a Phase 3 follow-on study evaluating the use of Polymyxin B Hemoperfusion (“PMX”) in a randomized controlled trial of adults treated for endotoxemia and septic shock. Enrollment:Robust enrollment activity continued throughout January 2024:85 patients enrolled to-date Four patients enrolled in the month of JanuaryClosing in on the interim enrollment target of 90 patients (“Interim Enrollment”); at Interim Enrollment, Baxter has the option to make the second milestone payment to Spectral to maintain its PMX exclusive distribution rights.Trial Sites:Continue...

Shelton, CT, Jan. 30, 2024 (GLOBE NEWSWIRE) — Exhibit 99.1 HUBBELL REPORTS FOURTH QUARTER 2023 AND FULL YEAR RESULTSQ4 diluted EPS from continuing operations of $3.16; adjusted diluted EPS from continuing operations of $3.69 Q4 net sales from continuing operations +10% (organic +8%) FY 2023 diluted EPS from continuing operations of $14.05; adjusted diluted EPS from continuing operations of $15.33 FY 2024 diluted EPS from continuing operations expected range of $14.40-$14.90; adjusted diluted EPS from continuing operations expected range of $16.00-$16.50SHELTON, CT. (January 30, 2024) – Hubbell Incorporated (NYSE: HUBB) today reported operating results for the fourth quarter and full year ended December 31, 2023. “Hubbell delivered a strong finish to a strong year,” said Gerben Bakker, Chairman, President and CEO. “For the full...

The first THC containing pharmaceutical preparations produced in Brazil approved by the Brazilian Health Regulatory Agency (Agencia Nacional de Vigilancia Sanitaria, “ANVISA”) TORONTO, Jan. 30, 2024 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is pleased to announce ANVISA has granted commercialization approval of Ease Labs Pharma (“Ease Labs”) pharmaceutical preparation produced in Brazil containing Avicanna’s Aureus branded active pharmaceutical ingredient (“API”). Ease Labs, a GMP-certified pharmaceutical company in Brazil, was granted approval from ANVISA to commercialize a pharmaceutical preparation product containing 2.5% of CBD and...

VANCOUVER, British Columbia, Jan. 30, 2024 (GLOBE NEWSWIRE) — Alaska Energy Metals Corporation (TSX-V: AEMC, OTCQB: AKEMF) (“AEMC” or the “Company”) is pleased to provide a corporate update that highlights the accomplishments made since inception in April 2023 and looks ahead to 2024 plans.             Alaska Energy Metals Corporation President & CEO Gregory Beischer commented: “I am very proud of what we have accomplished in just 10 months. We’ve successfully rebranded and recapitalized the Company; no small feat given challenging market conditions. For our Nikolai Nickel project in Alaska, we purchased a large database of historical information, calculated a significant maiden nickel resource, and identified drill targets to test for high-grade mineralization. With all our 2023 drill results now in hand, we will soon publish...

KUALA LUMPUR, Malaysia, Jan. 30, 2024 (GLOBE NEWSWIRE) — VCI Global Limited (NASDAQ: VCIG) (“VCI Global”, or the “Company”) is awarded an initial public offering (“IPO”) contract to list one of the largest Information Technology companies in Malaysia (“IT Company”), providing cutting-edge cross-border technology solutions and services. A Memorandum of Understanding (“MOU”) was inked yesterday between VCI Global and Legacy Corporate Advisory Sdn Bhd (“Legacy Corporate Advisory”), solidifying their commitment to establishing a strategic alliance. This collaborative venture reflects a dedication to mutual cooperation, leveraging respective strengths and resources, and jointly exploring new market opportunities, particularly in relation to IPOs on stock exchanges in the United States. This partnership has resulted in their first IPO...

Vancouver, BC, Jan. 30, 2024 (GLOBE NEWSWIRE) — Aben Minerals Ltd. (TSX-V: ABM) (OTCQB: ABNAF) (Frankfurt: R26) (“Aben” or “the Company”) has received and filed a NI 43-101 compliant Technical Report pertaining to Aben’s 100% owned 23,397 hectare Forrest Kerr Gold Project in the Golden Triangle, British Columbia. Forrest Kerr Property NI 43-101 Technical Reporthttps://www.sedarplus.ca/csa-party/records/document.html?id=585d4a5e38269d64535733304ea16aef03065042538b0119b10b7ab4ee2ce899 The Forrest Kerr Property From July 2016 to September 2021, Aben completed 22,957.5 m of diamond drilling in 72 drill holes, collected 1,282 soil samples, 371 rock samples, and 11 stream sediment samples, and completed an airborne magnetic survey over the Boundary valley totaling 173 line-kilometres of data. The global database for the property now...

ROLLE, Switzerland, Jan. 30, 2024 (GLOBE NEWSWIRE) — Garrett Motion Inc. (Nasdaq: GTX), a leading differentiated automotive technology provider, today announced it plans to issue financial results for the fourth quarter and full year 2023 on Thursday, February 15, 2024 before the open of market trading. Garrett will hold a conference call the same day at 8:30 am EDT / 2:30 pm CET. To participate in the conference call, please dial +1-877-883-0383 (US) or +1-412-902-6506 (international) and use the passcode 2659811. The conference call also will be broadcast over the internet and include a slide presentation. To access the webcast and supporting material, please visit the investor relations section of the Garrett Motion website at http://investors.garrettmotion.com/. A replay of the conference call will be available by dialing +1-877-344-7529...

MONTREAL, Jan. 30, 2024 (GLOBE NEWSWIRE) — NanoXplore Inc. (“NanoXplore” or “the Corporation”) (TSX: GRA and OTCQX: NNXPF), a world-leading graphene company, is pleased to announce that it has increased the production capacity of its St-Clotilde, QC plant to meet an existing customer’s need for increased graphene-enhanced SMC parts in an active program. This capacity expansion, which is part of its 5-year strategic plan and related to the SMC lightweighting initiative, begins immediately. This expansion, in two phases, will contribute $2M in incremental revenues during calendar 2024 and once fully scaled-up, is expected to contribute $8M to $10M annually beginning in calendar 2025. Moreover, a significant part of the capacity expansion costs will be assumed by the customer. Our customer has committed to purchase the additional...

– The Company will present various interaction functionalities to control smart glasses and digital devices, which can be easily integrated using the Mudra Development Kit – YOKNEAM ILLIT, ISRAEL, Jan. 30, 2024 (GLOBE NEWSWIRE) — Wearable Devices Ltd. (the “Company” or “Wearable Devices”) (Nasdaq: WLDS, WLDSW), a technology growth company specializing in AI-powered touchless sensing wearables, today announced its participation at SPIE Photonics West, a leading global conference focused on augmented, virtual, and mixed reality (“SPIE”), taking place in at the Moscone Center San Francisco from Tuesday, January 30 to Wednesday, January 31, 2024. The Company will be located at booth 6124. At SPIE, Wearable Devices will demonstrate various new input and control functionalities available through the Mudra Band, a neural wristband...

All of the cash payable to the plaintiffs in the settlement will be covered by Microbot’s insurance carrier and will not impact company’s cash position BRAINTREE, Mass., Jan. 30, 2024 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic Surgical System, today announced it has signed a Settlement Agreement and Release with Empery Asset Master Ltd., Empery Tax Efficient, LP, Empery Tax Efficient II, LP, Hudson Bay Master Fund Ltd. that resolves all claims asserted against the Company by these entities in a lawsuit filed in 2020 relating to a June 2017 securities purchase agreement. All of the cash payable to the plaintiffs in the settlement, representing over half of the settlement amount, will be covered by Microbot’s insurance carrier. This arrangement ensures...